Attached files

file filename
10-K - ANNUAL REPORT - Kedem Pharmaceuticals Inc.form10k.htm
EX-31.2 - Kedem Pharmaceuticals Inc.ex31-2.htm
EX-31.1 - Kedem Pharmaceuticals Inc.ex31-1.htm
EX-32.1 - Kedem Pharmaceuticals Inc.ex32-1.htm
EXCEL - IDEA: XBRL DOCUMENT - Kedem Pharmaceuticals Inc.Financial_Report.xls

 

Exhibit 32.2

 

Certification of Principal Financial Officer and Principal Accounting Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the annual report of Kedem Pharmaceuticals Inc. (the “Company”) on Form 10-K for the fiscal year ended May 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Audrey Lew, certify pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated:  August 28, 2012  
     
By: /s/ Audrey Lew  
  Audrey Lew  
  Chief Financial Officer  
  (Principal Financial Officer and Principal Accounting Officer)